| Fair Value of Financial Instruments |
(13) FAIR VALUE OF FINANCIAL INSTRUMENTS FASB ASC Topic 825, “Financial Instruments,” requires disclosure of fair value information about certain financial instruments, whether assets, liabilities, or off-balance-sheet commitments, if practicable. The following tables present the carrying amounts and fair values of the Company’s financial instruments as of December 31, 2025 and 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
Carrying
Amount |
|
|
Fair
Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and federal funds sold (1) |
|
$ |
201,564 |
|
|
$ |
201,564 |
|
|
$ |
200,814 |
|
|
$ |
750 |
|
|
$ |
— |
|
Investment securities |
|
|
60,183 |
|
|
|
60,183 |
|
|
|
— |
|
|
|
60,183 |
|
|
|
— |
|
Loans held for investment, net of allowance |
|
|
2,436,916 |
|
|
|
2,421,988 |
|
|
|
— |
|
|
|
— |
|
|
|
2,421,988 |
|
Loans held for sale, at lower of amortized cost or fair value |
|
|
15,144 |
|
|
|
15,144 |
|
|
|
— |
|
|
|
— |
|
|
|
15,144 |
|
Accrued interest receivable |
|
|
19,401 |
|
|
|
19,401 |
|
|
|
19,401 |
|
|
|
— |
|
|
|
— |
|
Equity securities (2) |
|
|
1,787 |
|
|
|
1,787 |
|
|
|
1,787 |
|
|
|
— |
|
|
|
— |
|
Financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funds borrowed (3) |
|
|
2,410,016 |
|
|
|
2,431,011 |
|
|
|
— |
|
|
|
2,431,011 |
|
|
|
— |
|
Accrued interest payable |
|
|
6,319 |
|
|
|
6,319 |
|
|
|
6,319 |
|
|
|
— |
|
|
|
— |
|
(1)Includes federal funds sold and interest bearing deposits in other banks. (2)Included within other assets on the balance sheet. (3)Excludes deferred financing costs of $8.4 million as of December 31, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
(Dollars in thousands) |
|
Carrying
Amount |
|
|
Fair
Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and federal funds sold (1) |
|
$ |
169,572 |
|
|
$ |
169,572 |
|
|
$ |
168,322 |
|
|
$ |
1,250 |
|
|
$ |
— |
|
Investment securities |
|
|
54,805 |
|
|
|
54,805 |
|
|
|
— |
|
|
|
54,805 |
|
|
|
— |
|
Loans held for investment, net of allowance |
|
|
2,265,428 |
|
|
|
2,238,645 |
|
|
|
— |
|
|
|
— |
|
|
|
2,238,645 |
|
Loans held for sale, at lower of amortized cost or fair value |
|
|
128,226 |
|
|
|
133,244 |
|
|
|
— |
|
|
|
— |
|
|
|
133,244 |
|
Accrued interest receivable |
|
|
15,314 |
|
|
|
15,314 |
|
|
|
15,314 |
|
|
|
— |
|
|
|
— |
|
Equity securities (2) |
|
|
1,732 |
|
|
|
1,732 |
|
|
|
1,732 |
|
|
|
— |
|
|
|
— |
|
Financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funds borrowed (3) |
|
|
2,379,413 |
|
|
|
2,371,434 |
|
|
|
— |
|
|
|
2,371,434 |
|
|
|
— |
|
Accrued interest payable |
|
|
8,231 |
|
|
|
8,231 |
|
|
|
8,231 |
|
|
|
— |
|
|
|
— |
|
(1)Includes federal funds sold and interest bearing deposits in other banks. (2)Included within other assets on the balance sheet. (3)Excludes deferred financing costs of $8.2 million as of December 31, 2024.
|